Latest Breaking News On - Globe newswire tscan therapeutics inc - Page 4 : comparemela.com

TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M D , M S , as Vice President, Clinical Development

WALTHAM, Mass., Feb. 06, 2024 TScan Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment.

United statesUniversity of cincinnatiDebora bartonJoyce allaireHeather savelleLife edit therapeutics incTranslational researchAmgen incGlobe newswire tscan therapeutics incOnyx pharmaceuticals incEarly development at elevatebioRubius therapeutics incClinical developmentDrexel university college of medicineLifesci advisorsSecurities exchange

TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024

Presentation to include additional results from ongoing Phase 1 study of TSC-100 and TSC-101 for the treatment of heme malignancies

United statesSan antonioJim murrayJyun wangNishant dwivediMonzrm al malkiJoyce allaireDebora bartonHyungc suhGavin macbeathNina abelowitzUdayr popatHenryb gonzHeather savelleShrikanta chattopadhyayErica buonomo

TScan Therapeutics Presents Initial Phase 1 Clinical

TScan Therapeutics Presents Initial Phase 1 Clinical
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesHeather savelleMonzrm al malkiDebora bartonGavin macbeathJoyce allaireAl malkiTscan therapeutics incGlobe newswire tscan therapeutics incLifesci advisorsAmerican society of hematologyDepartment of hematology hematopoietic cell transplantationSecurities exchangeAmerican societyAnnual meetingChief medical

TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition

TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMonzrm al malkiHeather savelleDebora bartonGavin macbeathAl malkiJoyce allaireDepartment of hematology hematopoietic cell transplantationGlobe newswire tscan therapeutics incLifesci advisorsAmerican society of hematology annual meetingTscan therapeutics incAmerican society of hematologySecurities exchangeTherapeutics presents initial phaseAmerican society

TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph D , as Chief Technology Officer

WALTHAM, Mass., Dec. 04, 2023 TScan Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment.

United statesJuno celgeneHeather savelleJustin mccueJoyce allaireGavin macbeathMassachusetts institute of technologySecurities exchangeGlobe newswire tscan therapeutics incUniversity of californiaLifesci advisorsTechnology officerTscan therapeutics incChief technologyChief executiveChief technology officer